Edgewise Therapeutics Inc [NASDAQ: EWTX] jumped around 10.43 points on Thursday, while shares priced at $29.50 at the close of the session, up 54.69%.
Compared to the average trading volume of 974.52K shares, EWTX reached a trading volume of 11846963 in the most recent trading day, which is why market watchdogs consider the stock to be active.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
What do top market gurus say about Edgewise Therapeutics Inc [EWTX]?
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for EWTX shares is $38.33 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on EWTX stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Piper Sandler have made an estimate for Edgewise Therapeutics Inc shares, keeping their opinion on the stock as Overweight, with their previous recommendation back on March 07, 2024. While these analysts kept the previous recommendation, Truist raised their target price to Buy. The new note on the price target was released on May 01, 2023, representing the official price target for Edgewise Therapeutics Inc stock. Previously, the target price had yet another raise to $5, while Goldman analysts kept a Sell rating on EWTX stock.
The Average True Range (ATR) for Edgewise Therapeutics Inc is set at 2.03 The Price to Book ratio for the last quarter was 5.41, with the Price to Cash per share for the same quarter was set at 5.46.
How has EWTX stock performed recently?
Edgewise Therapeutics Inc [EWTX] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 67.90. With this latest performance, EWTX shares gained by 49.59% in over the last four-week period, additionally plugging by 75.91% over the last 6 months – not to mention a rise of 378.12% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for EWTX stock in for the last two-week period is set at 78.49, with the RSI for the last a single of trading hit 83.93, and the three-weeks RSI is set at 73.95 for Edgewise Therapeutics Inc [EWTX]. The present Moving Average for the last 50 days of trading for this stock 18.94, while it was recorded at 20.47 for the last single week of trading, and 16.56 for the last 200 days.
Edgewise Therapeutics Inc [EWTX]: Deeper insight into the fundamentals
Edgewise Therapeutics Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 30.24 and a Current Ratio set at 30.24.
Earnings analysis for Edgewise Therapeutics Inc [EWTX]
With the latest financial reports released by the company, Edgewise Therapeutics Inc posted -0.41/share EPS, while the average EPS was predicted by analysts to be reported at -0.4/share. When compared, the two values demonstrate that the company fail the estimates by a Surprise Factor of -0.01. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for EWTX.
Insider trade positions for Edgewise Therapeutics Inc [EWTX]
There are presently around $112.54%, or 113.07%% of EWTX stock, in the hands of institutional investors. The top three institutional holders of EWTX stocks are: ORBIMED ADVISORS LLC with ownership of 15.02 million shares, which is approximately 17.1545%. RA CAPITAL MANAGEMENT, L.P., holding 8.91 million shares of the stock with an approximate value of $$160.45 million in EWTX stocks shares; and RA CAPITAL MANAGEMENT, L.P., currently with $$114.26 million in EWTX stock with ownership which is approximately 7.2452%.
